DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Keppra (Levetiracetam) - Adverse Event Reports - Serious Event - Drug Exposure During Pregnancy

 



Index of reports > Cases resulting in a serious event (494) > Cases with Drug Exposure During Pregnancy (125)

Below is the selection of adverse event reports related to Keppra (Levetiracetam) that includes cases resulting in a serious event where reactions include drug exposure during pregnancy.

 Reports 1 - 25 of 125   Next >>

Adverse event in 37 year old female receiving Keppra (Levetiracetam)

Reported by a physician from United States on 2007-10-25

Patient: 37 year old female

Adverse reactions / side effects: Cytogenetic Abnormality, Conversion Disorder, Uterine Contractions During Pregnancy, Premature Labour, Suicidal Ideation, Drug Exposure During Pregnancy, Breast Engorgement, Foetal Growth Retardation, Foetal Malformation, Amniocentesis Abnormal

Adverse event resulted in: hospitalization

Suspect drug(s):
Keppra (Levetiracetam)

Other drugs received by patient: Prenatal; Folic Acid



Adverse event in receiving Keppra (Levetiracetam)

Reported by a individual with unspecified qualification from United Kingdom on 2007-10-25

Patient:

Adverse reactions / side effects: Drug Exposure During Pregnancy, Talipes

Suspect drug(s):
Keppra (Levetiracetam)



Adverse event in receiving Keppra (Levetiracetam)

Reported by a individual with unspecified qualification from United Kingdom on 2007-10-25

Patient:

Adverse reactions / side effects: Drug Exposure During Pregnancy, Death Neonatal

Adverse event resulted in: death

Suspect drug(s):
Keppra (Levetiracetam)



Adverse event in receiving Keppra (Levetiracetam)

Reported by a individual with unspecified qualification from United Kingdom on 2007-10-25

Patient:

Adverse reactions / side effects: Drug Exposure During Pregnancy, Kidney Enlargement, Neonatal Disorder

Suspect drug(s):
Keppra (Levetiracetam)



Adverse event in female receiving Keppra (Levetiracetam)

Reported by a individual with unspecified qualification from United Kingdom on 2007-10-25

Patient: female

Adverse reactions / side effects: Drug Exposure During Pregnancy, Abortion Spontaneous

Suspect drug(s):
Keppra (Levetiracetam)



Adverse event in receiving Keppra (Levetiracetam)

Reported by a individual with unspecified qualification from United Kingdom on 2007-10-25

Patient:

Adverse reactions / side effects: Drug Exposure During Pregnancy, HIP Dysplasia

Suspect drug(s):
Keppra (Levetiracetam)



Adverse event in female receiving Keppra (Levetiracetam)

Reported by a individual with unspecified qualification from Germany on 2007-10-25

Patient: female

Adverse reactions / side effects: Drug Exposure During Pregnancy, Pregnancy

Suspect drug(s):
Keppra
    Dosage: 1500 mg 2/d

Keppra
    Dosage: 1000 mg 2/d



Adverse event in receiving Keppra (Levetiracetam)

Reported by a individual with unspecified qualification from United Kingdom on 2007-10-25

Patient:

Adverse reactions / side effects: Drug Exposure During Pregnancy, Talipes

Suspect drug(s):
Keppra (Levetiracetam)



Adverse event in 21 year old female receiving Keppra (Levetiracetam)

Reported by a consumer/non-health professional from United States on 2007-10-25

Patient: 21 year old female, weighing 88.6 kg (195.0 pounds)

Adverse reactions / side effects: Drug Exposure During Pregnancy, Abortion Induced, Pregnancy

Suspect drug(s):
Keppra (Levetiracetam)

Other drugs received by patient: Ortho TRI-Cyclen; Multi-Vitamin



Adverse event in receiving Keppra (Levetiracetam)

Reported by a individual with unspecified qualification from United Kingdom on 2007-10-25

Patient:

Adverse reactions / side effects: Syndactyly, Drug Exposure During Pregnancy

Suspect drug(s):
Keppra (Levetiracetam)



Adverse event in receiving Keppra (Levetiracetam)

Reported by a individual with unspecified qualification from United Kingdom on 2007-10-25

Patient:

Adverse reactions / side effects: Drug Exposure During Pregnancy, Pilonidal Cyst Congenital

Suspect drug(s):
Keppra (Levetiracetam)



Adverse event in 37 year old female receiving Keppra (Levetiracetam)

Reported by a consumer/non-health professional from United States on 2007-10-17

Patient: 37 year old female

Adverse reactions / side effects: Drug Exposure During Pregnancy, Premature Baby, Trisomy 18, Abortion Induced, Convulsion, Twin Pregnancy

Suspect drug(s):
Keppra
    Dosage: 1750 mg /d po
    Administration route: Oral
    Indication: Epilepsy
    End date: 2006-01-01

Keppra
    Dosage: 2000 mg /d po
    Administration route: Oral
    Indication: Epilepsy
    Start date: 2006-11-27

Other drugs received by patient: Phenobarbital TAB; Prenatal Vitamins; Folic Acid



Adverse event in 36 year old female receiving Keppra (Levetiracetam)

Reported by a physician from United States on 2007-10-16

Patient: 36 year old female

Adverse reactions / side effects: Drug Exposure During Pregnancy, Pregnancy, Congenital Choroid Plexus Cyst, Abortion Spontaneous, Complex Partial Seizures

Suspect drug(s):
Keppra
    Dosage: 3000 mg /d po
    Administration route: Oral
    Indication: Complex Partial Seizures
    Start date: 2003-03-01
    End date: 2006-09-29

Keppra
    Dosage: 4000 mg /d po
    Administration route: Oral
    Indication: Complex Partial Seizures
    Start date: 2006-09-29
    End date: 2006-11-27

Keppra
    Dosage: 4500 mg /d po
    Administration route: Oral
    Indication: Complex Partial Seizures
    Start date: 2006-11-27

Other drugs received by patient: Lamictal; Multi-Vitamin



Adverse event in female receiving Keppra (Levetiracetam)

Reported by a physician from United States on 2007-10-16

Patient: female, weighing 6.6 kg (14.5 pounds)

Adverse reactions / side effects: Drug Exposure During Pregnancy, Ventricular Septal Defect, Abortion Spontaneous, Congenital Choroid Plexus Cyst, Pregnancy

Suspect drug(s):
Keppra
    Dosage: 3000 mg /d trp
    Indication: Epilepsy
    Start date: 2006-05-01
    End date: 2006-09-29

Keppra
    Dosage: 4000 mg /d trp
    Indication: Epilepsy
    Start date: 2006-09-29
    End date: 2006-11-27

Keppra
    Dosage: 4500 mg /d trp
    Indication: Epilepsy
    Start date: 2006-11-27
    End date: 2007-02-20

Keppra
    Dosage: 4500 mg /d trm
    Indication: Epilepsy
    Start date: 2007-02-20
    End date: 2007-04-01

Other drugs received by patient: Lamictal; Folic Acid; Vitamin CAP



Adverse event in 36 year old female receiving Keppra (Levetiracetam)

Reported by a physician from United States on 2007-10-09

Patient: 36 year old female

Adverse reactions / side effects: Drug Exposure During Pregnancy, Abortion Spontaneous

Suspect drug(s):
Keppra (Levetiracetam)

Other drugs received by patient: Prenatal Vitamins; Folic Acid



Adverse event in male receiving Keppra (Levetiracetam)

Reported by a physician from United States on 2007-10-05

Patient: male, weighing 9.4 kg (20.7 pounds)

Adverse reactions / side effects: Drug Exposure During Pregnancy, Drug Exposure VIA Breast Milk, Ventricular Septal Defect, Pregnancy

Suspect drug(s):
Keppra
    Dosage: 1500 mg trp
    Indication: Epilepsy
    Start date: 2005-11-01
    End date: 2006-08-06

Keppra
    Dosage: 1500 mg trm
    Indication: Epilepsy
    Start date: 2006-08-06

Other drugs received by patient: Folic Acid; Prenatal Vitamins



Adverse event in male receiving Keppra (Levetiracetam)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-05

Patient: male, weighing 2.5 kg (5.6 pounds)

Adverse reactions / side effects: Weight Gain Poor, Dyspnoea, Pruritus, Nausea, Dental Caries, Anaemia, Failure TO Thrive, Convulsion, Drug Exposure During Pregnancy, Insomnia, Dacryostenosis Congenital, Depression, Complex Partial Seizures

Suspect drug(s):
Keppra (Levetiracetam)

Other drugs received by patient: Ambien; Kenalog; Prenatal Vitamins; Phenergan HCL; Albuterol; Metoclopramide; Prozac; Ferrous Sulfate TAB



Adverse event in female receiving Keppra (Levetiracetam)

Reported by a physician from United States on 2007-10-04

Patient: female, weighing 6.6 kg (14.5 pounds)

Adverse reactions / side effects: Trisomy 21, Drug Exposure During Pregnancy, Ventricular Septal Defect, Congenital Choroid Plexus Cyst, Pregnancy

Suspect drug(s):
Keppra
    Dosage: 4000 mg /d trp
    Indication: Epilepsy
    Start date: 2006-05-01
    End date: 2007-02-20

Keppra
    Dosage: 4000 mg /d trm
    Indication: Epilepsy
    Start date: 2007-02-20
    End date: 2007-04-01

Other drugs received by patient: Lamictal; Folic Acid; Vitamin CAP



Adverse event in male receiving Keppra (Levetiracetam)

Reported by a physician from United States on 2007-10-04

Patient: male, weighing 3.6 kg (7.9 pounds)

Adverse reactions / side effects: Drug Exposure During Pregnancy, Tendon Disorder, Anaemia, Talipes, Muscle Disorder

Suspect drug(s):
Keppra (Levetiracetam)

Other drugs received by patient: Prenatal Vitamins; Folic Acid; Chromagen



Adverse event in male receiving Keppra (Levetiracetam)

Reported by a physician from United States on 2007-10-02

Patient: male, weighing 18.5 kg (40.7 pounds)

Adverse reactions / side effects: Cardiac Murmur, Food Intolerance, Seborrhoeic Dermatitis, Ventricular Septal Defect, Premature Labour, Upper Respiratory Tract Infection, Drug Exposure During Pregnancy, Gastroenteritis, Pharyngitis Streptococcal, Gastrooesophageal Reflux Disease

Suspect drug(s):
Keppra (Levetiracetam)

Other drugs received by patient: Plaquenil; Prenatal Vitamins; Folic Acid; Lexapro; Clonazepam; Trileptal; Zantac



Adverse event in female receiving Keppra (Levetiracetam)

Reported by a physician from United States on 2007-10-02

Patient: female, weighing 2.3 kg (5.1 pounds)

Adverse reactions / side effects: Drug Exposure During Pregnancy, Premature Baby, Umbilical Hernia

Suspect drug(s):
Keppra
    Dosage: 500 mg trp
    Indication: Convulsion
    Start date: 2005-03-30

Keppra
    Dosage: 1000 mg trp
    Indication: Convulsion
    End date: 2006-08-29

Other drugs received by patient: Prenatal Vitamins



Adverse event in female receiving Keppra (Levetiracetam)

Reported by a individual with unspecified qualification from United States on 2007-07-30

Patient: female

Adverse reactions / side effects: Caesarean Section, Foetal Heart Rate Deceleration, Drug Exposure During Pregnancy, Premature Separation of Placenta, Gestational Diabetes

Adverse event resulted in: hospitalization

Suspect drug(s):
Keppra (Levetiracetam)

Other drugs received by patient: NPH Insulin



Adverse event in female receiving Keppra (Levetiracetam)

Reported by a individual with unspecified qualification from United States on 2007-07-30

Patient: female, weighing 3.8 kg (8.4 pounds)

Adverse reactions / side effects: Hypoglycaemia Neonatal, Caesarean Section, Drug Exposure During Pregnancy, Foetal Heart Rate Deceleration, Premature Separation of Placenta, Eczema, Jaundice Neonatal

Adverse event resulted in: hospitalization

Suspect drug(s):
Keppra (Levetiracetam)

Other drugs received by patient: NPH Insulin



Adverse event in 31 year old female receiving Keppra (Levetiracetam)

Reported by a physician from United States on 2007-07-26

Patient: 31 year old female

Adverse reactions / side effects: Caesarean Section, Umbilical Cord Abnormality, Vasa Praevia, Premature Baby, Drug Exposure During Pregnancy, Drug Exposure VIA Breast Milk

Suspect drug(s):
Keppra (Levetiracetam)

Other drugs received by patient: Prenatal Vitamins; Folic Acid



Adverse event in female receiving Keppra (Levetiracetam)

Reported by a health professional (non-physician/pharmacist) from Germany on 2007-07-26

Patient: female

Adverse reactions / side effects: Drug Exposure During Pregnancy, Unintended Pregnancy

Suspect drug(s):
Keppra (Levetiracetam)



 Page 1   Next >>

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009